Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma

Sponsor and Collaborators     
Children’s Oncology Group
National Cancer Institute (NCI)

Contact
Click here for contact info


Continue Reading

Investigator
Yael P. Mosse, MD     
Children’s Hospital of Philadelphia

ClinicalTrials.gov Identifier

NCT00939770